Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Wondercell Closes $14 Million in Angel Funding for Immune Cell Therapies

publication date: Feb 13, 2023

Wondercel Therapeutics, a Shenzhen next-gen immune cell therapy company, raised $14 million in an angel round from Yuansheng Venture, the only investor in the funding. Wondercel is led by the former CSO and Co-Founder of Nanjing’s Legend Biotech, Xiaohu Fan. Legend made its name by developing the first CAR-T therapy in China, Carvykti, an autologous BCMA targeting CAR-T approved in China, the US and EU for multiple myeloma. Dr Fan has said the new company will develop safer and less-expensive immune cell therapies for oncology, organ transplantation and autoimmune diseases. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here